DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
O'Donoghue ML, Bhatt DL, Wiviott SD et al.
Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin – Acute Coronary Syndromes Trial.
Circulation 2011;
123: 1843-1853
We do not assume any responsibility for the contents of the web pages of other providers.